Advertisement
Advertisement
MGX
Metagenomi Therapeutics, Inc. Common Stock
1.14
USDSponsored
+0.02
+1.79%
Sep 22, 15:58 UTC -4
Closed
After-Market
1.15
+0.01
+0.88%
Metagenomi Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 43.44M |
| Beta | 0.67 |
| Earnings Per Share (EPS) | -2.49 |
| Price-to-Book (P/B) Ratio | 0.37 |
| Operating Margin | -384.61% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -63.65% |
| Current Ratio | 4.50% |
| Free Cash Flow | -40.84M |
